Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 15187

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : November | Volume : 18 | Issue : 11 | Page : GC01 - GC05 Full Version

Analysing the Functional and Structural Impact of Single Nucleotide Polymorphisms in Matrix Metalloproteinase 3 Gene: An In-silico Approach


Published: November 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/73934.20249
Rejitha Ramachandran, Saritha C Joseph, kc Sajeevan, Shajee S Nair

1. Assistant Professor, Department of Biochemistry, Government Medical College, Manjeri, Kerala, India. 2. Assistant Professor, Department of Biochemistry, Government Medical College, Thrissur, kerala, India. 3. Professor, Department of Biochemistry, Government Medical College, Manjeri, Kerala, India. 4. Associate Professor, Department of Biochemistry, Government Medical College, Manjeri, Kerala, India.

Correspondence Address :
Dr. Shajee S Nair,
Government Medical College Manjeri Malappuram, Manjeri-676121, Kerala, India.
E-mail: drno2007@gmail.com

Abstract

Introduction: Matrix Metalloproteinase 3 (MMP3) is a vital member of the MMP family, known for its wide range of substrate specificity and proteolytic activity against Extracellular Matrix (ECM) components. The role of functional polymorphisms in the MMP genes has been previously investigated in relation to cancer susceptibility, particularly breast cancer. Several Single-Nucleotide Polymorphisms (SNPs) in the MMP3 gene have been linked to a number of clinical illnesses, such as Coronary Artery Disease (CAD); however, the results were not entirely conclusive.

Aim: To identify pathogenic missense SNPs in the human MMP3 gene and analyse their effects on structure and function.

Materials and Methods: This was a record-based cross-sectional study performed using data retrieved from online resources. The analysis was conducted using a series of different bioinformatic tools, for which ethical clearance was obtained from the institution. The online tools used included Sorting Intolerant from Tolerant (SIFT), PolyPhen-2, PhD-SNP, PANTHER, PROVEAN, and SNPs and GO to predict harmful non synonymous SNPs (nsSNPs). Further analysis was performed using I-Mutant 2.0, MutPred2, Consurf, and HOPE software. These tools were able to filter out damaging SNPs and predict the impact of deleterious SNPs on the structure and function of the MMP3 protein.

Results: This study predicted two potentially pathogenic SNPs (D175Y and Y116C) out of 443 missense SNPs from dbSNP, which is a database of SNPs available on the National Centre for Biotechnology Information website. Further analysis revealed that these SNPs were located in highly conserved regions and were predicted to decrease protein stability.

Conclusion: In this study, two potentially pathogenic SNPs (D175Y and Y116C) were identified. Characterisation of these SNPs can help us gain a better understanding of the molecular basis of clinical conditions. The results of this study can be further validated by designing population-based studies and wet lab experiments. This will help in augmenting research and personalised medicine.

Keywords

Computational molecular biology, Gene polymorphism, Human genome, Precision medicine

The human genome is relatively large, comprising approximately six billion nucleotides. About 99.9% of the DNA sequences in the human genome are the same across individuals, with individual variations accounting for the remaining 0.1% (1). Single Nucleotide Polymorphisms (SNPs), which refer to the substitution of a single nucleotide, are the most prevalent type of genetic variation. SNPs occur throughout the genome at a rate of one in every 1,000 base pairs. SNPs are broadly categorised into two types: synonymous and non synonymous (nsSNP). Non synonymous SNPs are responsible for protein variations and amino acid substitutions in humans, while synonymous SNPs do not change the amino acid sequences (2). With the development of practical and readily accessible DNA sequencing tools, SNPs have gained substantial clinical significance over the past two decades. Regardless of their effects on the biological function of gene products, SNPs are increasingly recognised as valuable markers in mapping complex human diseases, population genetics, and evolutionary studies (3). Efficient identification of important SNPs and understanding their impact on protein function will be beneficial for genetic studies aimed at elucidating the molecular basis of various diseases. Furthermore, targeted in-vitro and in-vivo experiments can be designed to predict the effects of specific SNPs (4). In light of this, multiple studies are being conducted to predict the functional consequences of nsSNPs, particularly based on sequence information and structural attributes (5),(6),(7),(8),(9),(10).

Matrix Metalloproteinases (MMPs) are a family of more than 25 zinc-containing enzymes that break down various proteoglycans, fibronectin, interstitial collagen, and basement membrane collagen during normal physiological remodelling and repair processes in development and inflammation (11). MMP-3, also known as Stromelysin-1, is a crucial member of the MMP family that exhibits a wide range of substrate specificity. Additionally, MMP-3 plays a critical role in the remodelling of connective tissue by activating other MMPs, such as collagenase, matrilysin, and gelatinase B (12),(13). The role of MMP gene functional polymorphisms in cancer susceptibility, especially breast cancer, has been previously investigated. The 5A/6A polymorphism has been linked to patient survival, oestrogen receptor status, breast cancer risk, and tumour size based on multiple genome-wide association analyses (14). However, the association between SNPs and breast cancer risk remains inconclusive and controversial, as it is largely influenced by the ethnicity of the population and sample size [14-16]. Apart from breast cancer, a meta-analysis indicates a significant correlation between gastrointestinal, colorectal, and oesophageal malignancies and the MMP-3-1171 5A/6A variation (17).

In addition to malignancies, MMP3 gene polymorphisms have been found to be associated with atherosclerosis. This is due to the critical role of MMP3 in the degradation of the Extracellular Matrix (ECM) of blood vessels. Several studies evaluating the influence of promoter polymorphism and MMP-3 (-1612 5A/6A) on CAD risk have produced contradictory results, including gender differences as well (18),(19),(20). Two MMP3 polymorphisms, rs520540 A/G and rs679620 C/T, were associated with cerebral stroke risk; however, contrary results were obtained in a different population, probably due to racial differences (21).

Among these reported SNPs, distinguishing functional SNPs from neutral SNPs is a major challenge. Experimental wet lab studies aimed at identifying the effects of multiple SNPs are time-consuming, challenging, and costly. Applying computational approaches to filter out possibly detrimental SNPs is emerging as a novel strategy for understanding the molecular mechanisms of diseases (22).

This was an in-silico study utilising bioinformatics computational tools with good predictive capabilities to identify the possible deleterious SNPs in the MMP-3 gene. Several studies have been conducted to find the association between specific SNPs in the MMP3 gene and diseases (14),(15),(16),(17),(18),(19),(20),(21). However, according to the literature search, there have been no comparable in-silico studies that examined every SNP in MMP-3 from the NCBI database. This study is expected to unravel the potential impact of polymorphisms on MMP3 structure and function. In addition, it can help in designing further specific experiments to confirm the importance of these SNPs in various clinical conditions. Combined with experimental data, it can aid in the development of personalised medicine.

Material and Methods

This online records-based cross-sectional study was conducted at Government Medical College, Manjeri, Kerala, India over a period from May to July 2024 (three months), which included data collection as well as analysis using online computational tools. IEC approval for this study was obtained from the institution (Ref. No: IEC/GMCM/133, date: 18/05/2024).

Methodology

The operational flow chart of this study is presented in (Table/Fig 1).

The detailed methodology is as follows:

1. Retrieval of SNPs in the MMP3 gene: The ncbi SNPs database (dbSNP) (https://www.ncbi.nlm.nih.gov/snp/) was used to retrieve all known SNPs for MMP-3 in humans (23). Non synonymous (missense) mutations were selected from the dataset for further analysis. The UniProt database was utilised to obtain the protein’s sequence and other pertinent information.

2. Prediction of the most deleterious missense SNPs: The retrieved missense SNPs were analysed using bioinformatics-based web tools for identification of high-risk nsSNPs. Details of the tools used are provided in (Table/Fig 2). Polymorphism phenotyping v2 (PolyPhen-2) and SIFT were the initial web-based tools employed. A SIFT score value between 0 and 1 indicates a potentially harmful effect, with scores below 0.05 being particularly concerning (24). A PolyPhen score ranging from 0.85 to 1 is considered probably damaging (25),(26). SNPs identified as potentially harmful by the aforementioned tools were further subjected to additional bioinformatics tools for confirmation and further refinement (27). The tools used included Predictions from Predictor of Human Deleterious Single Nucleotide Polymorphisms (PhD-SNP) (28), PANTHER-position-specific evolutionary preservation (29), PROVEAN (30), and SNPs and GO (31). SNPs projected by every tool to be harmful were selected for further examination.

3. Structural and functional analysis of SNP s with predicted damaging consequences:

a. Identification of impact on the structural and functional properties of MMP3: MutPred2 is a web application that integrates genetic and molecular data. It provides a ranked list of specific molecular changes with potential impacts on phenotype, along with a general pathogenicity prediction (32).
b. Prediction of change in stability of the MMP3 protein using I-Mutant 2.0 Suite: The influence of nsSNPs on protein stability was assessed using the I-Mutant 2.0, which utilises the free energy change value (Delta Delta G: DDG). The DDG represents the difference between the free energy of the folded wild-type and mutant structures. DDG values fall into three categories: neutral (-0.5 ≤ DDG ≤ 0.5 kcal/mol), mostly stable (DDG > 0.5 kcal/mol), or highly unstable (DDG < -0.5 kcal/mol) (33).
c. Prediction of evolutionary conservation of MMP3 using the ConSurf server: The ConSurf web server was used to examine the evolutionary rate of conservation of amino acids in MMP3. ConSurf determines the conservation scores of the protein’s amino acid positions by analysing the evolutionary relationships among similar sequences. The highest conserved location is graded as 9, while conservation values range from 1 to 9 (34).
d. Protein structure prediction and mutant analysis using HOPE software: The web-based application Have (y) Our Protein Explained (HOPE) is used to analyse how SNPs affect the structural conformation and functionality of proteins. HOPE uses data from multiple web services and databases to generate reports regarding the impact of SNPs, which include text, graphs, and animations (35).

Results

1. Data on SNPs retrieved: In the MMP3 gene, the dbSNP yielded a total of 4,120 SNPs. Among these SNPs, 443 were missense, 196 were synonymous, and 2,720 were located in the intronic region. For further in-silico research, only the missense or nsSNPs were selected. The remaining 761 SNPs belonged to other functional classes, for which authors were unable to retrieve information from dbSNP. The functional classes in dbSNP delineate the position of a polymorphism in relation to identifiable features of a specific gene transcript. Most functional classes are determined by the location of the variation in relation to the exon boundaries of the transcript (23). Since present study requires only missense SNPs, only those were retrieved and analysed. The remaining 3,677 SNPs were excluded from the manuscript due to our inability to obtain accurate information about their functional class.

2. Identification of predicted deleterious SNPs: The selected missense SNPs were subjected to SIFT and PolyPhen-2 to identify possible deleterious SNPs. Out of the 443 SNPs, 14 were predicted to be damaging by both SIFT and PolyPhen-2 (Table/Fig 3) (24),(25),(26). All 14 shortlisted SNPs identified by these two web-based techniques were further analysed using other bioinformatics tools: PhD-SNP, PANTHER, PROVEAN, and SNPs and GO (Table/Fig 4) (28),(29),(30),(31). Among all the analysed SNPs, two nsSNPs, rs201427128 (D175Y) and rs373783506 (Y116C), were predicted to be damaging by all six bioinformatics tools, including SIFT and PolyPhen.

3. Prediction by MutPred2 on structural and functional effects (32): The selected two detrimental SNPs were analysed using MutPred2, which suggested a significant impact on the 3D structure of the MMP3 protein (Table/Fig 5).

4. Prediction of changes in protein stability by I-Mutant 2.0 (33): I-Mutant predicted the extent to which the damaging SNPs alter the stability of the MMP3 protein. Both SNPs were predicted to decrease the stability of the protein (Table/Fig 6).

5. Consurf server results (34): An analysis of conservation using the ConSurf server revealed that both SNPs, D175Y and Y116C, were located in highly conserved areas and were found to be exposed residues (Table/Fig 7).

6. Predicted changes in the 3D structure of the MMP3 protein due to nsSNPs (35): HOPE software was used to generate results for both nsSNPs, with structural information obtained from the Protein Data Bank (PDB) database. The PDB ID used was 1SLM. In the case of D175Y, the mutant residue is larger, impacting hydrogen bond formation and its interaction with the metal ion in the original wild-type residue. Additionally, there is a disturbance in the ionic interaction made by the wild-type residue. For Y116C, the smaller residue results in an empty space in the protein core, which disrupts proper folding by causing a loss of hydrogen bonds in the core (Table/Fig 8).

Discussion

The MMP-3 gene, which codes for the MMP-3 protein, is a component of the MMP gene cluster located on chromosome 11q22.3. The NCBI gene ID for MMP3 is 4314, and its UniProt ID is P08254 (36),(37). The expression of the MMP3 gene may be regulated by DNA polymorphisms, which can exert allele-specific effects, resulting in fundamental variations in each person’s susceptibility to diseases and other traits (11).

The goal of the current study was to use several computational techniques to discover SNPs that could be harmful and alter the structure or function of the MMP3 gene. A significant number of researchers have utilised in-silico tools to predict the structural and functional impact of SNPs on proteins, such as the human CTLA4 gene (38), IL-33 gene (39), and the androgen receptor gene (27). This work represents the first comprehensive and systematic in-silico study of functional SNPs in the MMP3 gene.

Combining multiple computational methods can enhance the validity of predictions regarding damaging SNPs and improve efficiency. By employing six prediction methods (SIFT, PolyPhen-2, PROVEAN, PANTHER, PhD-SNP, and SNPs and GO), authors were able to obtain an integrated view of harmful SNPs in the MMP3 gene. Since each method relies on a different set of parameters, two ns SNPs (D175Y and Y116C) were identified as high-risk in present study, which were predicted to be harmful by every algorithm. Additional research revealed that these two ns SNPs might be dangerous because they are located in a highly conserved region and have the potential to affect protein stability (6),(7),(8),(9),(22),(27),(38),(39).

As an important member of the MMP3 family, several experimental studies have been conducted on genetic variation in MMP3, especially in malignancies (11),(13),(14),(15),(16),(17),(18),(21). Wang L et al., conducted an observational study and meta-analysis of MMP3 gene polymorphism in the Chinese population. The researchers concluded that while MMP-3 gene polymorphism raises the risk of ovarian cancer in the southern Chinese population, their meta-analysis showed that it had no effect on risk in other populations (40). Durmanova V et al., demonstrated that the MMP3 SNP rs3025058 influences the age of onset of Alzheimer’s disease (41).

The predicted ns SNPs from present study have not been linked to any clinical disease in published studies. Therefore, to support this finding, it is necessary to validate these ns SNPs through larger population-based studies and specifically designed wet lab experiments.

Limitation(s)

The present study utilised the limited dataset from the NCBI dbSNP database. More ns SNPs could have been analysed if other databases had been included.

Conclusion

Using a variety of bioinformatics techniques, this study has identified two significant nsSNPs, D175Y and Y116C, from the extensive SNP dataset of MMP3. Based on these findings, it can be concluded that these SNPs should be regarded as significant candidates for planning functional experiments involving the MMP3 gene. This presents an opportunity to investigate the molecular basis of any associated clinical problems and may aid in the discovery of potential drugs or pharmacological targets. Although computational biology is powerful, it has its limitations; therefore, population-based research is necessary to provide definitive validation.

References

1.
Teama S. DNA Polymorphisms: DNA-Based molecular markers and their application in medicine [Internet]. Genetic Diversity and Disease Susceptibility. InTech; 2018. Available from: https://dx.doi.org/10.5772/intechopen.79517. [crossref]
2.
Hossain MS, Roy AS, Islam MS. In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions. Sci Rep. 2020;10(1):14542.[crossref][PubMed]
3.
Wakui M. Analysis of Single Nucleotide Polymorphisms (SNPs). Rinsho Byori. 2013;61(11):1008-17.
4.
Chitrala KN, Yeguvapalli S. Computational screening and molecular dynamic simulation of breast cancer associated deleterious non-synonymous single nucleotide polymorphisms in TP53 gene. PloS one. 2014;9(8):e104242. [crossref][PubMed]
5.
George Priya Doss C, Rajasekaran R, Sudandiradoss C, Ramanathan K, Purohit R, Sethumadhavan R. A novel computational and structural analysis of nsSNPs in CFTR gene. Genomic Med. 2008;2(1-2):23-32. [crossref][PubMed]
6.
Nouira S, Bouatrous E, Ouragini H. An in-silico analysis of the coding and non-coding non-synonymous single nucleotide variants in the Npm1 gene to determine susceptibility to cancer. 2024. Available from: https://doi.org/10.2139/ ssrn.4871550. [crossref]
7.
Almakhari M, Chen Y, Kong AS, Moradigaravand D, Lai KS, Lim SH, et al. In-silico identification of deleterious non-synonymous SNPs of TBX1 gene: Functional and structural impact towards 22q11. 2DS. Plos one. 2024;19(6):e0298092. [crossref][PubMed]
8.
Subramanian S, Sanjeev K, Prakash PS, Appukuttan D. In silico analysis of single nucleotide polymorphisms of NAT-2 gene and its implications in periodontitis. Int J Chem Biochem Sci. 2023;24(8):177-81.
9.
Wiguna NY, Hawa P, Jonny J. Human PPARG gene mutation as risk factor for Type 2 diabetes melitus: In silico analysis. ASEAN Journal of Military and Preventive Medicine. 2024;1(1):01-02.
10.
Abdelazim AA, Maged M, Abdelmaksoud AI, Hassanin SE. In-silico analysis of nsSNPs in human CYP3A4/5 and their effects on drug-enzymes interactions of FDA-approved COVID-19 antiviral drugs: A pharmacogenetic study. 2024. Doi:10.21203/rs.3.rs-3910067/v1. [crossref]
11.
Munhoz, Godoy-Santos AL, Santos MC. MMP-3 polymorphism: Genetic marker in pathological processes. Mol Med Rep. 2010;3(5):735-40.
12.
Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuña JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739. [crossref][PubMed]
13.
Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996;271(22):13055-60. [crossref][PubMed]
14.
Suhaimi SA, Chan SC, Rosli R. Matrix Metallopeptidase 3 polymorphisms:emerging genetic markers in human breast cancer metastasis. J Breast Cancer. 2020;23(1):01-09. [crossref][PubMed]
15.
Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, et al. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: A meta-analysis of 50 case-control studies. Mutagenesis. 2010;25(1):41-48. [crossref][PubMed]
16.
Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res. 2002;8(12):3820-23.
17.
Aziz MA, Jafrin S, Barek MA, Anonna SN, Islam MS. MMP-3 -1171 5A/6Apromoter polymorphism and cancer susceptibility: An updated meta-analysis and trial sequential analysis. Future Oncol. 2023;19(21):1495-512. [crossref][PubMed]
18.
Wenwang L. Susceptibility of MMP3 gene polymorphism to coronary artery disease: A meta-analysis. J Med Biochem. 2023;42(4):685-93. [crossref][PubMed]
19.
Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol. 2003;41(12):2130-37. [crossref][PubMed]
20.
Koch W, de Waha A, Hoppmann P, Schömig A, Kastrati A. Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: Case-control study and a meta-analysis. Atherosclerosis. 2010;208(1):171-76. [crossref][PubMed]
21.
Yin Y, Zhang Y, Zhang X, Zhang Q, Wang J, Yang T, et al. Association of MMP3, MMP14, and MMP25 gene polymorphisms with cerebral stroke risk: A case-control study. BMC Med Genomics. 2023;16(1):297. [crossref][PubMed]
22.
Desai M, Chauhan J. In silico analysis of nsSNPs in human methyl CpG binding protein 2. Meta Gene. 2016;10:01-07. [crossref]
23.
Bhagwat M. Searching NCBI’s dbSNP database. Curr Protoc Bioinformatics. 2010;32(1):01-09. [crossref][PubMed]
24.
Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: Predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(W1):W452-57. [crossref][PubMed]
25.
Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;76(1):07-20. [crossref][PubMed]
26.
Gemovic B, Perovic V, Glisic S, Veljkovic N. Feature-based classification of amino acid substitutions outside conserved functional protein domains. Scientific World J. 2013;2013(1):948617. [crossref][PubMed]
27.
Adiba M, Das T, Paul A, Das A, Chakraborty S, Hosen MI, et al. In silico characterization of coding and non-coding SNPs of the androgen receptor gene. Informatics in Medicine Unlocked. 2021;24:100556. [crossref]
28.
Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics. 2006;22(22):2729-34. [crossref][PubMed]
29.
Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, Mi H. PANTHER: Making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31(1):08-22. [crossref][PubMed]
30.
Choi Y, Chan AP. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745-47. [crossref][PubMed]
31.
Capriotti E, Calabrese R, Fariselli P, Martelli PL, Altman RB, Casadio R. WS-SNPs&GO: A web server for predicting the deleterious effect of human protein variants using functional annotation. BMC Genomics. 2013;14:01-07. [crossref][PubMed]
32.
Pejaver V, Urresti J, Lugo-Martinez J, Pagel KA, Lin GN, Nam HJ, et al. Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nat Commun. 2020;11(1):5918. [crossref][PubMed]
33.
Capriotti E, Fariselli P, Casadio R. I-Mutant2. 0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33(suppl_2):W306-10. [crossref][PubMed]
34.
Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T, et al. ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016;44(W1):W344-50. [crossref][PubMed]
35.
Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010;11:548. [crossref][PubMed]
36.
Sherry ST, Ward M, Sirotkin K. dbSNP—database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 1999;9(8):677-79. [crossref][PubMed]
37.
UniProt Consortium. UniProt: The Universal protein knowledge base in 2023. Nucleic Acids Res. 2023;51(D1):D523-31.
38.
Irfan M, Iqbal T, Hashmi S, Ghani U, Bhatti A. Insilico prediction and functional analysis of nonsynonymous SNPs in human CTLA4 gene. Sci Rep. 2022;12(1):20441. [crossref][PubMed]
39.
Falahi S, Karaji AG, Koohyanizadeh F, Rezaiemanesh A, Salari F. A comprehensive in Silico analysis of the functional and structural impact of single nucleotide polymorphisms (SNPs) in the human IL-33 gene. Comput Biol Chem. 2021;94:107560. [crossref][PubMed]
40.
Wang L, Yao Y, Si D. MMP-3 gene regulates the carcinogenesis and metabolic process of ovarian cancer, evidence from a Chinese population: Observational study and meta-analysis. Medicine. 2023;102(50):e36471. [crossref][PubMed]
41.
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 polymorphisms on clinical findings in Alzheimer’s disease patients. Mediators Inflamm. 2021;2021(1):5573642.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2024/73934.20249

Date of Submission: Jul 01, 2024
Date of Peer Review: Aug 01, 2024
Date of Acceptance: Sep 25, 2024
Date of Publishing: Nov 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? No
• For any images presented appropriate consent has been obtained from the subjects. No

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 02, 2024
• Manual Googling: Aug 06, 2024
• iThenticate Software: Sep 24, 2024 (14%)

ETYMOLOGY: Author Origin

EMENDATIONS: 8

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com